Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01257997 · ClinicalTrials.gov registry record
Quantification of Human Adipogenesis
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 20
- Enrollment target
NCT01257997 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 20 participants.
The verdict
NCT01257997 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This pilot study is using a novel technology to measure the rate of turnover of new fat cells. Analysis of volunteer samples is ongoing, however the study is currently not enrolling new volunteers.
Interventions
- BIOLOGICAL 15N-Thymidine, 2H-Water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-12 |
| Est. Completion | 2017-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01257997
The ClinicalTrials.gov registry entry for NCT01257997 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 15N-Thymidine, 2H-Water is the first listed.
NCT01257997 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01257997 about?
NCT01257997 is a clinical study titled "Quantification of Human Adipogenesis". This pilot study is using a novel technology to measure the rate of turnover of new fat cells. Analysis of volunteer samples is ongoing, however the study is currently not enrolling new volunteers.
What is the current status of trial NCT01257997?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2010-12. Estimated completion is 2017-01.
What interventions are being tested in trial NCT01257997?
The interventions under investigation include: 15N-Thymidine, 2H-Water (BIOLOGICAL).
Who is sponsoring clinical trial NCT01257997?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.